Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 3Completed 2Withdrawn 1Unknown 1Suspended 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 4Genitourinary 3Other hematologic neoplasm 2CNS 2Breast 2Thoracic 1Sarcoma 1Plasma cell 1Myeloid 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Pulmonary Fibrosis 1Lung Neoplasms 1

Interventions

Carboplatin 181pembrolizumab 156Pemetrexed 129Cisplatin 97Drug Therapy 67Paclitaxel 59osimertinib 56Magnetic Resonance Spectroscopy 50durvalumab 49Specimen Handling 49Radiotherapy 49Nivolumab 49atezolizumab 43Docetaxel 43Etoposide 40Bevacizumab 39Blood Specimen Collection 33tislelizumab 31Radiosurgery 31Gemcitabine 29130-nm albumin-bound paclitaxel 27Immunotherapy 25Immune Checkpoint Inhibitors 25cemiplimab 23Injections 23aflutinib 20Cetuximab 18Biopsy 18Standard of Care 17Platinum Compounds 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Positron-Emission Tomography × Thoracic × Clear all
NCT03535545 2026-02-27

Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients

Massachusetts General Hospital

Phase 1 Recruiting
100 enrolled
Thoracic

Lung Neoplasms, Pulmonary Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡